Home > Healthcare > Pharmaceuticals > Finished Drug Form > Demulcent Eye Drops Market
Demulcent Eye Drops Market size was worth more than USD 1.8 billion in 2021 and is expected to grow at a CAGR of more than 6% through 2030. Easy product accessibility and increased availability will push industry growth.
Growing cases of various eye disorders across the world is the primary factor propelling the market expansion. Recent data reveals that dry eye disease (DED) affects around 5% adult Americans. Notably, DED leads to numerous complications such as microaneurysm, optic nerve injury, and retinal thickness. Increase in instances of dry eye disease is one of the main factors that will boost demand for demulcent eye drops. Additionally, higher pervasiveness of ocular ailments across developing nations, especially among geriatric population will augment the demulcent eye drops market outlook.
Report Attribute | Details |
---|---|
Base Year: | 2021 |
Demulcent Eye Drops Market Size in 2021: | USD 1.8 Billion |
Forecast Period: | 2022 to 2030 |
Forecast Period 2022 to 2030 CAGR: | 6% |
2030 Value Projection: | USD 3 Billion |
Historical Data for: | 2017 to 2021 |
No. of Pages: | 240 |
Tables, Charts & Figures: | 238 |
Segments covered: | Active Pharmaceutical Ingredient Type, Drug Formulation, Medication Type, Distribution Channel, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|